- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Molecular Imprints, Inc. (MII), the leader in nano-imprint lithography, announced that it has elected Edward C. Grady, President and Chief Executive Officer at Brooks Automation, to its Board of Directors. Mr. Grady brings a wealth of experience to MII and our Board with over 30 years of experience in strategic marketing sales, product marketing and operations management.
Prior to joining Brooks Automation, Mr. Grady ran several divisions at KLA-Tencor, served as president and CEO of Hoya Micro Mask and was vice president of worldwide sales at Monsanto/MEMC where he started his career. Mr. Grady currently serves on the Board of Brooks Automation Inc. (BRKS), Evergreen Solar (ESLR), Integrated Materials Inc. and New Wave Research.
"I am happy to join Molecular Imprints' Board of Directors with their strong leadership and outstanding technology," said Ed Grady. "The tremendous potential of their imprint technology is on the brink of realization and I am pleased to have the opportunity to participate at this time of transformation."
"We are pleased to welcome Ed to the Molecular Imprints Board of Directors with his significant business experience," said Mark Melliar-Smith, CEO of Molecular Imprints. "I am confident that his broad knowledge base will be an invaluable addition to our board and help us continue to make further progress in all phases of our business."
About Molecular Imprints, Inc.
Molecular Imprints, Inc. (MII) develops and manufactures nano-imprint lithography systems for high resolution and 3-dimensional patterning. The company has commercialized a proprietary Step and Flash® imprint lithography (S-FIL®) technology, which is a room temperature, low pressure and drop-on-demand imprint process that has demonstrated sub-20 nanometer resolution. Molecular Imprints systems and solutions enable leading edge manufacturing of nanotechnology, solid state lighting, semiconductors, and magnetic data storage devices.
For more information, please click here
Molecular Imprints, Inc., Austin
John Doering, 512-334-1202
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016